Other · developed by Jade Biosciences
JADE201 is a sterile solution administered by subcutaneous injection.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07533955 | Phase 1 | Rhematoid Arthritis | Recruiting | JBIO |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Rhematoid Arthritis
Updated Oct 18, 2026. Something wrong or missing? Report it on the JBIO page.
See JBIO's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
JBIO catalysts and pipeline →